B. Sankaran

1.1k total citations
6 papers, 79 citations indexed

About

B. Sankaran is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, B. Sankaran has authored 6 papers receiving a total of 79 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in B. Sankaran's work include Lung Cancer Treatments and Mutations (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Advanced Breast Cancer Therapies (1 paper). B. Sankaran is often cited by papers focused on Lung Cancer Treatments and Mutations (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Advanced Breast Cancer Therapies (1 paper). B. Sankaran collaborates with scholars based in United States, Netherlands and Switzerland. B. Sankaran's co-authors include Naidong Weng, Richard W. Edom, Wenying Jian, David J. Sharkey, Severn B. Churn, Boyd E. Haley, Robert J. DeLorenzo, Robert V. Swift, Egbert F. Smit and Takashi Seto and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Molecular Cancer Therapeutics.

In The Last Decade

B. Sankaran

6 papers receiving 79 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Sankaran United States 5 28 26 19 12 10 6 79
Saori Kinjo Japan 7 71 2.5× 17 0.7× 17 0.9× 7 0.6× 10 1.0× 10 134
Karina Standahl Olsen Norway 7 32 1.1× 24 0.9× 12 0.6× 35 2.9× 4 0.4× 9 115
Eric Wever Netherlands 8 93 3.3× 4 0.2× 9 0.5× 7 0.6× 12 1.2× 13 170
Liliana R. Santos Portugal 5 51 1.8× 20 0.8× 62 3.3× 3 0.3× 11 1.1× 9 168
Jianeng Zhang China 5 33 1.2× 6 0.2× 6 0.3× 9 0.8× 14 1.4× 8 139
Signe Bek Sørensen Denmark 5 41 1.5× 8 0.3× 12 0.6× 2 0.2× 4 0.4× 8 128
Gregory Gordon United States 5 117 4.2× 11 0.4× 29 1.5× 14 1.2× 5 0.5× 6 230
William Yang United Kingdom 4 32 1.1× 16 0.6× 7 0.4× 2 0.2× 8 0.8× 4 59
Myriam Boyer-Clavel France 4 38 1.4× 6 0.2× 12 0.6× 8 0.7× 7 0.7× 5 95
Guoping Sun China 7 90 3.2× 19 0.7× 22 1.2× 22 1.8× 2 0.2× 19 182

Countries citing papers authored by B. Sankaran

Since Specialization
Citations

This map shows the geographic impact of B. Sankaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Sankaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Sankaran more than expected).

Fields of papers citing papers by B. Sankaran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Sankaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Sankaran. The network helps show where B. Sankaran may publish in the future.

Co-authorship network of co-authors of B. Sankaran

This figure shows the co-authorship network connecting the top 25 collaborators of B. Sankaran. A scholar is included among the top collaborators of B. Sankaran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Sankaran. B. Sankaran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Heist, Rebecca S., Edward B. Garon, Daniel S.W. Tan, et al.. (2020). B11 Accurate Detection of METex14 Mutations in Non-Small Cell Lung Cancer (NSCLC) with Comprehensive Genomic Sequencing: Results from the GEOMETRY Mono-1 Study. Journal of Thoracic Oncology. 15(2). S30–S31. 5 indexed citations
2.
Heist, Rebecca S., Edward B. Garon, Daniel S.W. Tan, et al.. (2019). Abstract A029: Biomarker analysis of patients with METΔex14 mutated non-small-cell lung cancer (NSCLC) treated with capmatinib in the GEOMETRY mono-1 study. Molecular Cancer Therapeutics. 18(12_Supplement). A029–A029. 3 indexed citations
3.
4.
5.
Torres, Rodrigo, Robert V. Swift, Nicholas Chim, et al.. (2011). Biochemical, Structural and Molecular Dynamics Analyses of the Potential Virulence Factor RipA from Yersinia pestis. PLoS ONE. 6(9). e25084–e25084. 16 indexed citations
6.
Churn, Severn B., B. Sankaran, Boyd E. Haley, & Robert J. DeLorenzo. (1993). Ischemic Brain Injury Selectively Alters ATP Binding of Calcium and Calmodulin-Dependent Protein Kinase II. Biochemical and Biophysical Research Communications. 193(3). 934–940. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saori Kinjo Breakdown of academic impact, for papers by Karina Standahl Olsen Breakdown of academic impact, for papers by Eric Wever Breakdown of academic impact, for papers by Liliana R. Santos Breakdown of academic impact, for papers by Jianeng Zhang Breakdown of academic impact, for papers by Signe Bek Sørensen Breakdown of academic impact, for papers by Gregory Gordon Breakdown of academic impact, for papers by William Yang Breakdown of academic impact, for papers by Myriam Boyer-Clavel Breakdown of academic impact, for papers by Guoping Sun
Rankless by CCL
2026